La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
Charmacy Pharmaceutical Gestione
Gestione criteri di controllo 4/4
Charmacy Pharmaceutical's CEO is Chuanglong Yao, appointed in Mar 2000, has a tenure of 24.42 years. total yearly compensation is CN¥728.07K, comprised of 87.4% salary and 12.6% bonuses, including company stock and options. directly owns 31.97% of the company’s shares, worth HK$272.79M. The average tenure of the management team and the board of directors is 2.3 years and 5.4 years respectively.
Informazioni chiave
Chuanglong Yao
Amministratore delegato
CN¥728.1k
Compenso totale
| Percentuale dello stipendio del CEO | 87.4% |
| Mandato del CEO | 24.4yrs |
| Proprietà del CEO | 32.0% |
| Durata media del management | 2.3yrs |
| Durata media del Consiglio di amministrazione | 5.4yrs |
Aggiornamenti recenti sulla gestione
Recent updates
There Could Be A Chance Charmacy Pharmaceutical Co., Ltd.'s (HKG:2289) CEO Will Have Their Compensation Increased
May 13
There's Reason For Concern Over Charmacy Pharmaceutical Co., Ltd.'s (HKG:2289) Massive 40% Price Jump
Apr 24Charmacy Pharmaceutical Co., Ltd. (HKG:2289) Stock's 26% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Jan 19These 4 Measures Indicate That Charmacy Pharmaceutical (HKG:2289) Is Using Debt Reasonably Well
Oct 25If EPS Growth Is Important To You, Charmacy Pharmaceutical (HKG:2289) Presents An Opportunity
Sep 17Is Charmacy Pharmaceutical (HKG:2289) A Risky Investment?
May 02What Type Of Returns Would Charmacy Pharmaceutical's(HKG:2289) Shareholders Have Earned If They Purchased Their SharesThree Years Ago?
Mar 15Are Dividend Investors Making A Mistake With Charmacy Pharmaceutical Co., Ltd. (HKG:2289)?
Feb 17We Wouldn't Rely On Charmacy Pharmaceutical's (HKG:2289) Statutory Earnings As A Guide
Jan 27Returns On Capital At Charmacy Pharmaceutical (HKG:2289) Paint An Interesting Picture
Jan 09What Charmacy Pharmaceutical Co., Ltd.'s (HKG:2289) ROE Can Tell Us
Dec 22
Reflecting on Charmacy Pharmaceutical's (HKG:2289) Share Price Returns Over The Last Three Years
Nov 29Analisi delle retribuzioni degli amministratori delegati
| Data | Compenso totale | Stipendio | Guadagni aziendali |
|---|---|---|---|
| Dec 31 2023 | CN¥728k | CN¥636k | CN¥51m |
| Sep 30 2023 | n/a | n/a | CN¥74m |
| Jun 30 2023 | n/a | n/a | CN¥96m |
| Mar 31 2023 | n/a | n/a | CN¥93m |
| Dec 31 2022 | CN¥732k | CN¥638k | CN¥90m |
| Sep 30 2022 | n/a | n/a | CN¥54m |
| Jun 30 2022 | n/a | n/a | CN¥18m |
| Mar 31 2022 | n/a | n/a | CN¥20m |
| Dec 31 2021 | CN¥679k | CN¥646k | CN¥23m |
| Sep 30 2021 | n/a | n/a | CN¥29m |
| Jun 30 2021 | n/a | n/a | CN¥36m |
| Mar 31 2021 | n/a | n/a | CN¥38m |
| Dec 31 2020 | CN¥685k | CN¥649k | CN¥41m |
| Sep 30 2020 | n/a | n/a | CN¥35m |
| Jun 30 2020 | n/a | n/a | CN¥29m |
| Mar 31 2020 | n/a | n/a | CN¥34m |
| Dec 31 2019 | CN¥714k | CN¥650k | CN¥40m |
| Sep 30 2019 | n/a | n/a | CN¥41m |
| Jun 30 2019 | n/a | n/a | CN¥42m |
| Mar 31 2019 | n/a | n/a | CN¥44m |
| Dec 31 2018 | CN¥715k | CN¥649k | CN¥45m |
| Sep 30 2018 | n/a | n/a | CN¥46m |
| Jun 30 2018 | n/a | n/a | CN¥47m |
| Mar 31 2018 | n/a | n/a | CN¥46m |
| Dec 31 2017 | CN¥713k | CN¥650k | CN¥45m |
Compensazione vs Mercato: Chuanglong's total compensation ($USD102.11K) is below average for companies of similar size in the Hong Kong market ($USD235.49K).
Compensazione vs guadagni: Chuanglong's compensation has been consistent with company performance over the past year.
AMMINISTRATORE DELEGATO
Chuanglong Yao (54 yo)
24.4yrs
Mandato
CN¥728,071
Compensazione
Mr. Chuanglong Yao has been Chief Executive Officer at Charmacy Pharmaceutical Co., Ltd. since March 2000 and serves as its Vice Chairman since May 31, 2023 and served as its Chairman since May 2015. Mr. Y...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| CEO & Vice Chairman | 24.4yrs | CN¥728.07k | 31.97% CN¥ 272.8m | |
| CFO & Executive Director | 2.3yrs | CN¥385.49k | Nessun dato | |
| VP & Executive Director | 9yrs | CN¥991.13k | Nessun dato | |
| Chief Logistics Officer & CTO | no data | CN¥188.00k | Nessun dato | |
| Joint Company Secretary | 2.3yrs | Nessun dato | Nessun dato | |
| Joint Company Secretary | 2.3yrs | Nessun dato | Nessun dato |
2.3yrs
Durata media
45yo
Età media
Gestione esperta: 2289's management team is considered experienced (2.3 years average tenure).
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| CEO & Vice Chairman | 24.4yrs | CN¥728.07k | 31.97% CN¥ 272.8m | |
| CFO & Executive Director | 2.1yrs | CN¥385.49k | Nessun dato | |
| VP & Executive Director | 9.3yrs | CN¥991.13k | Nessun dato | |
| Independent Non-Executive Director | 8.7yrs | CN¥144.00k | Nessun dato | |
| Independent Non-Executive Director | 8.7yrs | CN¥50.00k | Nessun dato | |
| Independent Supervisor | 9.3yrs | Nessun dato | Nessun dato | |
| Employee Representative Supervisor | 9.3yrs | Nessun dato | Nessun dato | |
| Independent Non-Executive Director | 1.3yrs | CN¥29.30k | Nessun dato | |
| Non-Executive Director | 2.1yrs | Nessun dato | Nessun dato | |
| Non-Executive Chairman | 2.2yrs | Nessun dato | Nessun dato | |
| Non-Executive Director | 1.3yrs | Nessun dato | Nessun dato | |
| Chairman of the Board of Supervisors | 1.3yrs | Nessun dato | Nessun dato |
5.4yrs
Durata media
49yo
Età media
Consiglio di amministrazione esperto: 2289's board of directors are considered experienced (5.4 years average tenure).